Rectal cancer drug trial of dostarlimab cures all patients: report - Fox News


6/10/2022 12:00:00 AM2 years 10 months ago
by Ann Schmidt

A clinical trial of dostarlimab, done by Memorial Sloan Kettering Cancer Center, found the drug appears to have completely cured 12 patients of rectal cancer.

The results of a small clinical trial have found that there could be a cure for rectal cancer.  The trial conducted by Memorial Sloan Kettering Cancer Center in Manhattan involved at least 12 rectal… [+2873 chars]

full article...